Latest News

Uniseed Newsletter – September 2015

In this newsletter we talk about two of our investees: Hatchtech and Dr. Reddy’s Laboratories sign US$197 million commercial  agreement for next generation head lice treatment Uniseed investee ProGel Pty Ltd releases Perkii® probiotic drink.  ...

ProGel Pty Ltd releases Perkii® probiotic drink

  Uniseed, UniQuest and Brisbane Angels start-up ProGel has begun test marketing of its patented, low calorie, juice and water probiotic drink (Perkii®) in selected stores in Brisbane and the Gold Coast, including: University of Queensland Lolly Shop Pando Café -...

Verva Pharmaceuticals Signs Deals with Two Biotechs

Verva Pharmaceuticals Limited, a public unlisted Australian biotechnology company developing a novel class of insulin sensitizers to treat patients with diabetes, today announced it had signed separate agreements with two biotechnology companies to sell its...

Uniseed Newsletter – June 2015

In this newsletter we talk about eight of our investees: Novartis acquires Uniseed investee company, Spinifex Pharmaceuticals,  for US$200m plus milestone payments. Hatchtech M&A process to commercialize Xeglyze™ lotion. Verva signs deals with two private...

OccuRx launched with up to AU$6.5 M in funding

OccuRx, an Australian biopharmaceutical company developing a new class of drugs to prevent a significant health burden associated with fibrosis, was launched today with up to AU$6.5M in staged tranches of venture capital funding from a consortium including the Medical...

MEDIA ENQUIRIES
Interested in our investees?
Contact us.